True Innovations Report is a monthly stock newsletter from Stansberry Research, edited by Josh Baylin. Stansberry says it shows subscribers how to invest in technology trends it expects to play out over several years, and the seller points to its own track record and historical data for those claims. No third-party audit of the picks’ results appears on the seller’s pages, so the most useful test of whether it works for you is the 30-day period the seller gives you to decide.
The seller’s page lists a promotional first-year price of $129 and annual renewal at $199 plus applicable taxes; confirm both at checkout before subscribing. The rest of this guide covers what the seller says it offers, how its track record is presented, and what to check before you pay.
What is True Innovations Report?
The seller describes it as a research advisory that shows subscribers how to invest in what it calls the next technology revolutions. The product page lists these details:
| Item | What the seller’s page lists |
|---|---|
| Publication schedule | Monthly, on the third Friday of each month |
| Starting capital | About $1,000, described as suited to beginning investors |
| Asset type | Stocks |
| Number of positions | About 30 |
| Typical holding period | 3 to 5 years |
| Editor | Josh Baylin |
| Lead equity analyst | John Engel |
Other businesses may use similar names, so check the publisher name on any offer before you pay.
What do you get with a subscription?
The product page describes a monthly research advisory with about 30 positions, and it gives you 30 days to decide whether to keep the subscription. Confirm any bonus items and their terms on the checkout page before you buy.
How much does it cost, and what happens at renewal?
The seller’s page lists a promotional first-year price of $129 and annual renewal at $199 plus applicable taxes. The seller states that the subscription renews automatically each year, may be cancelled by phone at 1-888-261-2693 or online, and must be cancelled one day before the renewal date to avoid the renewal fee. Confirm these terms in writing before you buy.
Does True Innovations Report work?
The only results on the seller’s pages come from the seller. The product page says its figures are estimates based upon its track record and historical data, and that positions, safety and returns may vary. The product page does not include a record of past picks.
The seller’s pitch claims past gains of 851% on Lumentum and 1,183% on Ciena, but it does not provide the complete recommendation record needed to assess those figures in context. A few large winners do not tell you what a typical subscriber earned, and they do not show how many picks lost money.
The testimonials on the page are quotes the seller chose to publish. They describe how readers felt about the research and do not report investment results.
Who might this suit, and who should wait?
The seller describes the newsletter as suited to beginning investors with about $1,000. It fits someone who is comfortable holding stocks for three to five years and reading a monthly issue. It may not suit you if you need the money within a few years, or if you would be buying on the strength of a news story rather than a plan. The offer page pushes you to act quickly. The 30-day period gives you time to read the first issues before renewal, so the deadline is not a reason to skip the checks in this guide.
How do refunds and cancellation work?
The seller states that you may contact member services within the first 30 days for a full refund; confirm the written policy at checkout. Cancellation terms were not verified here either, so confirm how and when to cancel before you pay. Keep the date you cancelled and any confirmation you receive.
Who runs it, and how can you check the seller?
Stansberry Research is the seller. The product page names Josh Baylin as editor and John Engel as lead equity analyst. It says Baylin began at Bloomberg News in Washington, D.C., moved to Legg Mason and S.A.C. Capital as an analyst and investor, and later became vice president of product, marketing and analytics at Brain Corp. These are the seller’s descriptions of its editors, and this page does not verify them.
To check the seller yourself, ask for the full list of past recommendations with buy dates, sell dates and losses. Compare the terms you receive in writing with what the checkout shows.
For background on how federal rules are published, the FDA website lists the agency’s work, and rule texts are posted at regulations.gov. Neither site covers this newsletter, so use them for background, not as a verdict on it.
How does it compare with other paid money programs?
If you are weighing it against other paid newsletters, our Safe Money Report Review covers price and risk questions for a different product. For a general checklist to use on any paid income or investing program, read How to Evaluate Online Income Courses, which sets out the questions to ask before you pay. Remember the do-it-yourself option too: building your own picks means reading company reports, choosing positions and monitoring them, which is the work the subscription is selling. Decide whether you want that time.
Before you order
- Ask customer service for the full written record of past picks, including the ones that fell and the largest drop in the portfolio.
- Check the first-year price, the renewal amount and the renewal date on the checkout page on the day you buy.
- Set a reminder to cancel before renewal if you do not want to continue, and read the written cancellation terms first.
- Read the written refund policy before you pay.
By HealthDataConsortium.org Research Team
